Sunjoy Prabakaran

  • Geno4ME Study Show How Whole Genome Sequencing May Impact Routine Genetic Screening

    Geno4ME Study Show How Whole Genome Sequencing May Impact Routine Genetic Screening

    Population genetic screening is evolving beyond targeted panels as next-generation sequencing (NGS) technology makes whole genome sequencing (WGS) more efficient and accessible

    Read Article
  • Providence whole genome sequencing program could help transform population health

    Providence whole genome sequencing program could help transform population health

    Read Article
  • New Blood Test Could Change the Way Cancer is Detected.

    New Blood Test Could Change the Way Cancer is Detected.

    This single blood test screens for more than 50 cancers by looking at blood for DNA shed by cancer tumors.

    Read Article
  • How Immunotherapy is Used to Treat Cancer

    How Immunotherapy is Used to Treat Cancer

    Read Article
  • Whole Genome Sequencing Poised to Transform Routine Genetic Screening

    Whole Genome Sequencing Poised to Transform Routine Genetic Screening

    Population genetic screening is evolving beyond targeted panels as next-generation sequencing (NGS) technology makes whole genome sequencing (WGS) more efficient and accessible.

    Read Article
  • Study Shows Genomic Testing Can Improve Outcomes for those with Advanced Cancer

    Study Shows Genomic Testing Can Improve Outcomes for those with Advanced Cancer

    Providence Genomics and EACRI researchers conducted a multi-year study of the impact of removing testing barriers to comprehensive genomic profiling (CGP) for patients with advanced cancers.

    Read Article
  • Using Cancer Risk Screening Assessments in Routine Care to Personalize Care Planning and Genetic Testing Access

    Using Cancer Risk Screening Assessments in Routine Care to Personalize Care Planning and Genetic Testing Access

    An estimated 90 percent of individuals with inherited cancer risk do not know they are at risk.

    Read Article
  • Understanding the Progression of Ductal Carcinoma in Situ (DCIS) to Invasive Breast Cancer (IBC)

    Understanding the Progression of Ductal Carcinoma in Situ (DCIS) to Invasive Breast Cancer (IBC)

    This study includes authors from Providence Genomics in collaboration with Providence Swedish Cancer Institute.

    Read Article
  • Digital Pathology (DP) Using AI is Transforming Analysis & Diagnosis in Clinical Practice

    Digital Pathology (DP) Using AI is Transforming Analysis & Diagnosis in Clinical Practice

    This innovative Artificial Intelligence (AI) technology involves the digitization of traditional glass slides which enables pathologists to access, analyze, and share high-resolution whole-slide image

    Read Article
  • New Research Evaluates the Success and Challenges of Novel Transplant Treatment

    New Research Evaluates the Success and Challenges of Novel Transplant Treatment

    Xenotransplantation—the grating or transplanting of organs or tissues between members of different species

    Read Article
  • Everett-Based Providence Comprehensive Breast Center Launches Free, Personalized Cancer Screening and Early Detection Program

    Everett-Based Providence Comprehensive Breast Center Launches Free, Personalized Cancer Screening and Early Detection Program

    Everett-based Providence Comprehensive Breast Center is the first program in Providence’s seven-state health system to launch a free, personalized cancer screening and early detection system.

    Read Article
  • Providence Contribution to Novel AI Model Opens the Door to Accelerating Clinical Discovery and Advancing Patient Care

    Providence Contribution to Novel AI Model Opens the Door to Accelerating Clinical Discovery and Advancing Patient Care

    This research highlights a new artificial intelligence model that Providence, Microsoft, and the University of Washington used to diagnose cancer.

    Read Article
  • Comprehensive Genomic Profiling leads to better patient outcomes, a new joint study says

    Comprehensive Genomic Profiling leads to better patient outcomes, a new joint study says

    Widespread Adoption of Precision Anticancer Therapies After Implementation of Pathologist-Directed Comprehensive Genomic Profiling Across a Large US Health System

    Read Article
  • Providence launches groundbreaking study to elevate real-world use of multi-cancer early detection

    Providence launches groundbreaking study to elevate real-world use of multi-cancer early detection

    Providence Genomics and Providence-Swedish Cancer Institute have launched the PREVAIL study,

    Read Article
  • Early Detection for More Patients: Prevention4ME expands and includes more data

    Early Detection for More Patients: Prevention4ME expands and includes more data

    Prevention4ME has identified more than 2600 patients at high risk for cancer who are now being screened differently or receiving NCCN guideline-recommended genetic testing

    Read Article
  • Break through Research Early sequencing offers a 67% chance of changing treatments and improved survival.

    Break through Research Early sequencing offers a 67% chance of changing treatments and improved survival.

    Research from a team led by Brian Piening, PhD, Program Director for Providence Genomics that included colleagues from across Providence as well as collaborators at Illumina and Microsoft

    Read Article
  • Introducing BiomedParse: A new AI foundation model for faster, smarter, all-in-one image analysis

    Introducing BiomedParse: A new AI foundation model for faster, smarter, all-in-one image analysis

    A wide variety of medical imaging tools (CT,MRI, pathology etc.) are used in routine medical care, and represent robust datasets for potential biomedical discovery using Artificial Intelligence (AI)

    Read Article
  • Two immune patterns help predict how head and neck cancer patients respond to immunotherapy

    Two immune patterns help predict how head and neck cancer patients respond to immunotherapy

    New Providence research published in Nature-Precision Oncology finds that in head and neck cancer, researchers found that two specific immune response patterns

    Read Article
  • Providence weighs in: How genetic testing is reshaping everyday care

    Providence weighs in: How genetic testing is reshaping everyday care

    Genetic testing has moved beyond academic centers to being reflected in clinical guidelines adopted by a growing number of clinicians

    Read Article
  • Providence whole genome sequencing program shows transformative potential for population health

    Providence whole genome sequencing program shows transformative potential for population health

    A new study from researchers at Providence, published in Nature NPJ Genomic Medicine, demonstrates how Whole Genome Sequencing (WGS) can transform health care

    Read Article
  • loading
    Loading More...
See more